SCHEMBL7910189

SCHEMBL7910189

CCOCCOc1ccc2c(c1)C(C(N)=O)CC(C)(C)O2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 6/20 0.41
KCNQ1 P51787 6/20 0.41
ALDH1A1 P00352 5/20 0.39
GAA P10253 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 2/20 0.39
CASP1 P29466 2/20 0.39
HSD17B10 Q99714 2/20 0.39
EPHX2 P34913 2/20 0.39
GLA P06280 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CASP7 P55210 1/20 0.37
KCNH2 Q12809 1/20 0.37
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
NCF1 P14598 2/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900351 0.88 KCNE1 (0.41) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL7910194 0.81 NCF1 (0.38) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL6602375 0.77 KCNE1 (0.49) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL6600854 0.75 KCNE1 (0.46) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL7909655 0.74 CNR1 (0.40) ALDH1A1GAASMN1; SMN2MEN1KMT2A
SCHEMBL7910113 0.72 ALDH1A1 (0.37) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL6601750 0.72 KCNE1 (0.43) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL7470852 0.72 KCNE1 (0.47) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL6605946 0.71 KCNE1 (0.55) KCNE1KCNQ1ALDH1A1GAAKDM4E
SCHEMBL7913670 0.70 ATM (0.44) ALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177449-B1 CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-01-23 US disclosed